No Data
No Data
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Xilio Therapeutics Shares Are Trading Higher After the Company Announced 7.85 Million of Its Shares Was Acquired by Gilead Sciences.
Gilead Sciences Acquires $1.83 Million in Xilio Therapeutics Stock
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
Xilio To Present Initial Data From Its Ongoing Phase 2 Trial For Vilastobart At ASCO GI; Reports Preliminary Phase 1 Data For XTX301 Showing Improved Tolerability Profile Over Historical Data For RhIL-12
Press Release: Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer